Zions Trust National Association’s Bristol-Myers Squibb BMY Stock Holding History

Zions Trust National Association’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$98K	Hold	1,650	–	–	0.14%	60
2014 Q3	$84K	Hold	1,650	–	–	0.12%	63
2014 Q2	$80K	Hold	1,650	–	–	0.11%	66
2014 Q1	$85K	Hold	1,650	–	–	0.12%	65
2013 Q4	$87K	Hold	1,650	–	–	0.12%	64
2013 Q3	$77K	Hold	1,650	–	–	0.11%	68
2013 Q2	$74K	Buy	+1,650	New	+$71.6K	0.1%	74

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zions Trust National Association's BMY Position: Q4 2014 in Review

Zions Trust National Association held its Bristol-Myers Squibb (BMY) position steady in Q4 2014 at 1,650 shares worth $98K. The position accounts for 0.14% of the portfolio, ranked #60.

Zions Trust National Association first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. 1,411 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

Zions Trust National Association held 1,650 shares of Bristol-Myers Squibb worth $98K as of Q4 2014.
Zions Trust National Association left its Bristol-Myers Squibb share count unchanged in Q4 2014.
Bristol-Myers Squibb made up 0.14% of Zions Trust National Association's portfolio in Q4 2014, its #60 holding.
Zions Trust National Association first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
1,411 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Zions Trust National Association's 13F filing for Q4 2014, filed 12 Jan 2015.